P3 Health Partners Inc. (PIIIW) stock

PIIIWNasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIII

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/30

$0.01+0.00 (+14.89%)

Close on Oct 30, 2026Market cap $29.26MP/E –Yield –

P3 Health Partners r&d expenses

Research and development expenses are spending on new products and technology.

P3 Health Partners has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in P3 Health Partners's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-50 reverse split on Apr 14, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PIIIW.

Revenue growth2.8% · median 20.4%

Operating margin-9.9% · median 1.9%

Net margin-6.6% · median 1.2%

Advertisement
300 × 250